{
    "organizations": [],
    "uuid": "9757c901c9c26a779e673af7fbe49311e62a7ac4",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-syntheticmr-gets-regulatory-cleara/brief-syntheticmr-gets-regulatory-clearance-from-fda-idUSFWN1PN03Z",
    "ord_in_thread": 0,
    "title": "BRIEF-SyntheticMR Gets Regulatory Clearance From FDA‍​",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 29 (Reuters) - SYNTHETICMR AB (PUBL):\n* SEGMENTATION AND QUANTIFICATION OF BRAIN TISSUE, AND INDUSTRY FIRST MYELIN VOLUME MEASUREMENTS IN SYMRI NOW FDA CLEARED‍​\n* SYNTHETICMR AB (PUBL) - SAYS ‍SYMRI AS A WHOLE CAN NOW BE OFFERED TO CLINICS AND HOSPITALS ON US MARKET. Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-01-29T15:06:00.000+02:00",
    "crawled": "2018-01-30T19:00:29.022+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "syntheticmr",
        "ab",
        "publ",
        "segmentation",
        "quantification",
        "brain",
        "tissue",
        "industry",
        "first",
        "myelin",
        "volume",
        "measurement",
        "symri",
        "fda",
        "syntheticmr",
        "ab",
        "publ",
        "say",
        "whole",
        "offered",
        "clinic",
        "hospital",
        "u",
        "market",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}